Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility

Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus

(2019) Shih-Yao Chen et al.   CLINICAL RHEUMATOLOGY

Novel paradigms in systemic lupus erythematosus

(2019) Thomas Dörner et al.   LANCET

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases

(2019) Sarah Y. Weißenberg et al.   Frontiers in Immunology

Postactivated B cells in systemic lupus erythematosus

(2018) Eva Schrezenmeier et al.   CURRENT OPINION IN RHEUMATOLOGY

Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RA-FOXP3hi Regulatory Subset and Follow-Up Disease Severity

(2017) Aleš Goropevšek et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus

(2017) Richard Furie et al.   Arthritis & Rheumatology

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

(2016) Munther Khamashta et al.   ANNALS OF THE RHEUMATIC DISEASES

STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus

(2016) Chuanlin Ding et al.   JOURNAL OF IMMUNOLOGY

Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE

(2016) Thomas Dörner et al.   Nature Reviews Rheumatology

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts

(2016) Caroline H. Shiboski et al.   Arthritis & Rheumatology

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

(2015) Kenneth C Kalunian et al.   ANNALS OF THE RHEUMATIC DISEASES

Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases

(2015) Andreia C. Lino et al.   IMMUNOLOGICAL REVIEWS

Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells

(2013) Elissa K. Deenick et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

(2012) Thomas Rose et al.   ANNALS OF THE RHEUMATIC DISEASES

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Activation of the interferon-γ signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells

(2009) Thomas Karonitsch et al.   ARTHRITIS AND RHEUMATISM

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

(2008) Robert Biesen et al.   ARTHRITIS AND RHEUMATISM